Literature DB >> 10397074

Mixed connective tissue disease.

R Kasukawa1.   

Abstract

Mixed connective tissue disease deserves to be a distinct disease entity due to the persistent citation of this disease in the literature since the original description by Sharp in 1972, in spite of the presence of several criticisms against the independency of this disease. The characteristic features of mixed connective tissue disease are: 1) the presence of anti-U1snRNP antibody with high titers in sera, 2) an increased frequency of HLA-DR4 in the leukocytes, and 3) death due to pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397074     DOI: 10.2169/internalmedicine.38.386

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  14 in total

1.  Nucleoporin p62 antibodies in a case of mixed connective tissue disease.

Authors:  Doris M Kraemer; Michael R Kraus; Christian Kneitz; Hans-Peter Tony
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  A case of mixed connective tissue disease complicated with hypertrophic obstructive cardiomyopathy.

Authors:  Hideki Nakamura; Seiko Tateishi; Atsushi Kawakami; Hiroaki Ida; Taku Fukuda; Michiyo Sasaki; Yuji Koide; Naoto Ashizawa; Shinji Seto; Tomayoshi Hayashi; Shinichi Sato; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2008-05-21       Impact factor: 2.631

3.  Long-term outcome in polymyositis and dermatomyositis.

Authors:  I M Bronner; M F G van der Meulen; M de Visser; S Kalmijn; W J van Venrooij; A E Voskuyl; H J Dinant; W H J P Linssen; J H J Wokke; J E Hoogendijk
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

4.  A Rare Case of Mixed Connective Tissue Disease (MCTD) with Intricate Features of Lupus, Polymyositis and Rheumatoid Arthritis Presenting with Severe Myositis.

Authors:  Lokesh S; Kadavanu Tony; Suresh V; Balakrishna Malepati
Journal:  J Clin Diagn Res       Date:  2015-03-01

5.  Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.

Authors:  Tsutomu Hamada; Takuya Samukawa; Tomohiro Kumamoto; Kazuhito Hatanaka; Go Tsukuya; Masuki Yamamoto; Kentaro Machida; Masaki Watanabe; Keiko Mizuno; Ikkou Higashimoto; Yoshikazu Inoue; Hiromasa Inoue
Journal:  BMC Pulm Med       Date:  2015-09-30       Impact factor: 3.317

Review 6.  Melkersson-Rosenthal syndrome as an early manifestation of mixed connective tissue disease.

Authors:  Dorota Jasinska; Jerzy Boczon
Journal:  Eur J Med Res       Date:  2015-12-23       Impact factor: 2.175

7.  Residual salivary secretion ability may be a useful marker for differential diagnosis in autoimmune diseases.

Authors:  Etsuko Maeshima; Hiroya Koshiba; Kanako Furukawa; Shinichiro Maeshima; Wataru Sakamoto
Journal:  Dis Markers       Date:  2014-11-20       Impact factor: 3.434

8.  Retinal Vasculitis and Choroidopathy in Pediatric-Onset Mixed Connective Tissue Disease.

Authors:  Bradley Postlethwaite; Henry G Wynn; Debendra Pattanaik; Shelley Ost; Charles B MacDonald; R Christopher Walton; Seunghyun Kim; Linda K Myers; Monica Brown Lobbins
Journal:  J Clin Rheumatol       Date:  2017-10       Impact factor: 3.517

9.  Immunogenicity of influenza H1N1 vaccination in mixed connective tissue disease: effect of disease and therapy.

Authors:  Renata Miossi; Ricardo Fuller; Júlio C B Moraes; Ana Cristina M Ribeiro; Carla G S Saad; Nadia E Aikawa; Joao L Miraglia; Maria A Ishida; Eloisa Bonfa; M Teresa C Caleiro
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

Review 10.  Protein-losing Gastroenteropathy Related to Mixed Connective Tissue Disease: A Case Report of a Successful Outcome and Literature Review.

Authors:  Yuya Kobayashi; Yasuhiro Shimojima; Yasufumi Kondo; Ryota Takamatsu; Daigo Miyazaki; Dai Kishida; Yoshiki Sekijima; Shu-Ichi Ikeda
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.